The effect of aryl hydrocarbon receptor ligands on the expression of AhR, AhRR, ARNT, Hif1α, CYP1A1 and NQO1 genes in rat liver

被引:59
作者
Brauze, Damian
Widerak, Magdalena
Cwykiel, Joanna
Szyfter, Krzysztof
Baer-Dubowska, Wanda
机构
[1] Polish Acad Sci, Inst Human Genet, PL-60479 Poznan, Poland
[2] Karl Marcinkowski Univ Med Sci, Dept Pharmaceut Biochem, PL-60780 Poznan, Poland
关键词
AhR; ARNT; CYP1A1; beta-naphthoflavone; 3-methylcholanthrene; 2,3,7,8-tetrachlorodibenzo-p-dioxin;
D O I
10.1016/j.toxlet.2006.09.010
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The aryl hydrocarbon receptor (AhR) mediates a variety of biological responses to ubiquitous environmental pollutants. AhR together with ARNT, AhRR, HIF1 alpha represent a novel basic helix-loop-helix/PAS family of transcriptional regulators. Their interplay may affect the xenobiotic response. In this study, the effect of i.p. administration of different AhR ligands on the expression of AhR, AhRR, ARNT, HIF1 alpha and CYP1A1 and NAD(P)H: quinone oxidoreductase (NQO1), the enzymes controlled by AhR were examined in Sprague-Dawley rat liver. Quantitative real-time RT-PCR analysis revealed no changes in the mRNA expression of ARNT and HIF1 alpha following 3-methylcholanthrene (3-MC), 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) or P-naphthoflavone (BNF) treatment. AhRR expression was affected by TCDD but not by BNF and 3-MC. Expression of AhR mRNA and of the markers of its activation, CYP1A1 and NQO1, was significantly increased by administration of TCDD, 3-MC and, to lower extent, BNF. These results indicate that binding of the ligands to AhR up-regulates the mRNA transcription not only of CYP1A1 and NQO1, but also of AhR itself. The level of AhR induction depends on the potency of xenobiotic metabolizing enzymes inducer. (c) 2006 Elsevier Ireland Ltd. All fights reserved.
引用
收藏
页码:212 / 220
页数:9
相关论文
共 52 条
[51]   Aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries [J].
Tijet, N ;
Boutros, PC ;
Moffat, ID ;
Okey, AB ;
Tuomisto, J ;
Pohjanvirta, R .
MOLECULAR PHARMACOLOGY, 2006, 69 (01) :140-153
[52]  
Viluksela M, 2000, CANCER RES, V60, P6911